Lundbeck
HLUN-B.CO
#2869
Rank
A$6.81 B
Marketcap
$7.08
Share price
0.54%
Change (1 day)
-2.95%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

EPS for Lundbeck (HLUN-B.CO)

EPS in 2023 (TTM): $0.53

According to Lundbeck 's latest financial reports the company's current EPS (TTM) is $0.55. In 2022 the company made an earnings per share (EPS) of $0.42 a decrease over its 2021 EPS that were of $0.95.

EPS history for Lundbeck from 2009 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$0.5326.21%
2022$0.42-55.47%
2021$0.95-51.83%
2020$1.96-28.01%
2019$2.73-44.08%
2018$4.8851.94%
2017$3.21126.64%
2016$1.42-120.84%
2015-$6.805622.18%
2014-$0.12-110.03%
2013$1.18-28.08%
2012$1.65-52.1%
2011$3.44-1.31%
2010$3.4815.61%
2009$3.01